Table 2. Evaluation of anthropometric measurements and laboratory findings of the patients by groups.
Control | NAS | NASH | p-Value* | p-Value** | |
Height Z score | -0.36±0.78 | 0.32±1.45 | 0.90±1.35 | 0.072 | 0.001 |
Weight Z score | -0.01±0.59 | 1.55±1.20 | 2.30±1.32 | 0.007 | <0.001 |
BMI | 18.49±4.04 | 24.90±4.12 | 27.96±5.61 | 0.012 | <0.001 |
BMI Z score | 0.58±0.92 | 1.59±1.02 | 2.15±1.18 | 0.022 | <0.001 |
Glucose (mg/dL) | 83±7.74 | 92.71±9.93 | 92.50±20.89 | 0.959 | 0.001 |
AST (U/L) | 31.05±6.00 | 23.40±9.78 | 58.42±29.89 | <0.001 | <0.001 |
ALT (U/L) | 32.65±4.41 | 20.55±10.06 | 99.00±67.57 | <0.001 | <0.001 |
GGT (U/L) | 24.71±11.12 | 19.46±13.23 | 35.28±14.24 | <0.001 | <0.001 |
ALP (U/L) | 198.11±73.66 | 208.54±96.69 | 253.19±111.41 | 0.058 | 0.062 |
T.bil (mg/dL) | 0.44±0.18 | 0.49±0.31 | 0.51±0.34 | 0.784 | 0.592 |
D.bil (mg/dL) | 0.15±0.06 | 0.34±1.35 | 0.21±0.19 | 0.620 | 0.614 |
Cholesterol (mg/dL) | 154.63±19.84 | 151±30.61 | 163.93±34.25 | 0.087 | 0.140 |
Triglycerides (mg/dL) | 77.85±14.06 | 114.83±59.07 | 150.46±67.92 | 0.011 | <0.001 |
Vitamin D (ng/ml) | 29.70±7.51 | 19.72±10.20 | 15.84±6.83 | 0.031 | <0.001 |
PTH (pg/mL) | 43.28±10.87 | 51.15±16.51 | 46.98±18.58 | 0.276 | 0.050 |
Ca (mg/dL) | 9.98±0.33 | 10.08±0.51 | 10.04±0.45 | 0.628 | 0.597 |
P (mg/dL) | 4.44±0.59 | 4.32±0.67 | 4.44±0.70 | 0.424 | 0.570 |
Mg (mg/dL) | 2.05±0.21 | 2.13±0.18 | 2.12±0.13 | 0.750 | 0.117 |
TAS (mmol Trolox equivalent/L) | 1.25±0.14 | 1.53±0.28 | 1.63±0.26 | 0.116 | <0.001 |
TOS (µmol H2O2 Eqv/L) | 12.67±8.06 | 38.74±16.10 | 36.01±16.90 | 0.706 | <0.001 |
Catalase (kU/L) | 128.13±113.06 | 453.04±233.95 | 403.97±218.79 | 0.339 | <0.001 |